University of Ghana, Regional Institute for Population Studies
Legon, Ghana
NCT Number: NCT07284914
This research project aims to test the effect of two interventions targeted to community pharmacies in the Greater Accra region, Ghana, on antibiotics dispensing rates. The general goal is to inform the design of future policies to address the rising threat of antimicrobial resistance.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Legon, Ghana
Interventions that discourage community pharmacies from providing antibiotics without proper diagnosis and a physician's prescription are critically needed in low- and middle-income countries in order to address the rising threat of antimicrobial resistance. In this study, we will test the effect of two interventions targeted to community pharmacies in the Greater Accra region of Ghana. We will conduct a baseline survey, followed by visits by standardized patients (SPs). We will then implement the interventions (described below) and assess the outcomes again using SPs.
The study has 4 key objectives:
Objective 1. Assess the effect of two behavioral interventions targeted to community pharmacies on antibiotics dispensing rates. We randomly assign 285 pharmacies in Greater Accra 1:1:1 into one of three arms: 1) Control, 2) Individualized Feedback, and 3) Legal Reminder. In the Individualized Feedback arm, we use information from the first visits to provide customized feedback to the pharmacies. In the Legal Reminder arm, we provide a letter from the Ghana authorities emphasizing that providing antibiotics without a physician prescription is against the law.
Objective 2. Assess the extent of know-do gap in antibiotics dispensing behavior among community pharmacies. We compare self-reported data from a baseline survey and the one obtained from SP visits to assess the gap between what the pharmacies know and what they do in practice.
Objective 3. Examine the effect of reduced pressure from patients for antibiotics on pharmacies' dispensing behavior. The two demand variations we will test are the following: 1) Patient asks for a medicine (normal demand pressure), 2) Patient explicitly says that they would prefer not to take antibiotics and mention that they do not have a physician prescription and that their condition appears to be viral (reduced demand pressure).
Objective 4. Assess differential effects of the two interventions and reduced demand pressure across patient's age.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for community pharmacies:
Exclusion criteria
We use information from the baseline visits (e.g., on whether they give antibiotics without a prescription and the time they spend with patients) to provide customized feedback to the pharmacies.
We provide a letter from the authorities in Ghana emphasizing that providing antibiotics without a physician prescription is against the law.
Time frame: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.
Whether the pharmacy dispenses antibiotics without prescription in scenarios not requiring them
Time frame: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.
Whether the dispensed antibiotics fall into the Watch or Reserve category in the WHO AWaRE classification.
Time frame: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.
Amount patients spend out-of-pocket on medications including antibiotics.
Time frame: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.
Whether the pharmacist recommends the patient to see a doctor before antibiotics can be dispensed.
Time frame: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.
Number of questions asked by the pharmacist based on a pre-specified checklist of appropriate history taking behavior
Time frame: From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.
Amount of time the pharmacist spends on the patient before giving medicine.
Penn State University
Other
Acronym: CITAR-Ghana
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07267689
Cold Symptom, Common Cold
Kielce, Poland
View Trial DetailsNCT06907355
Cough, Infections
Santiago, Chile
View Trial DetailsNCT06149494
COPD, COPD Exacerbation Acute
London, United Kingdom
View Trial DetailsNCT05577065
Infections, Respiratory Tract Diseases
Cork, Ireland
View Trial Details